BEN-MAIMON CAROLE bought LRMR
January 26, 2026 · Form 4 insider transaction
BEN-MAIMON CAROLE bought 600,600 shares of Larimar Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
600,600
Price
$0.00
Total value
N/A
InsiderBEN-MAIMON CAROLE
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 26, 2026
Filing dateJanuary 27, 2026
Shares owned after600,600
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.